ConductScience.org, home

Library / Trial comparisons

Early Stage Dementia vs Normative Older Adults: serious adverse events

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 1000.228wilsonClinicalTrials.gov
Risk in group 2000.299wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20-0.2990.228newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 2loga group has no participants with the outcomeClinicalTrials.gov
Odds ratio, group 1 over group 2loga cell of the two-by-two table is zeroClinicalTrials.gov
Number needed to harmfrom the risk difference intervalthe two groups' risks are equalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Early Stage DementiaIndividuals with early stage dementia who attended a Adult Day Care Program at least twice a week.013EG000ClinicalTrials.gov
Group 2Normative Older AdultsNormative older adults with no known history of neurological condition.09EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, serious adverse eventsClinicalTrials.gov
Time frameClinicalTrials.gov

Trial 8

FieldValueSource
TitleEffects of Strengthening Exercise on the Brain for Early Dementia and Normative Older AdultsClinicalTrials.gov
NCT numberNCT01264614ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsCognitive Decline, Dementia, Alzheimer's Disease, Mild Cognitive ImpairmentClinicalTrials.gov
InterventionsStrengthening exerciseClinicalTrials.gov
Lead sponsorUnion College, New YorkClinicalTrials.gov
Results first posted2015-03-11ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01264614?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.